Artificial Intelligence in Urologic Malignancies describes current artificial intelligence technology with an emphasis on prostate cancer applications. It provides guidance on how artificial intelligence can improve therapeutics, how the power of artificial intelligence integrated with current standard therapy and research can enhance decision making and proposes future directions on how to integrate artificial intelligence within clinical applications. This is the perfect reference for scientists and researchers interested in the basic translational research opportunities such as drug discovery, pharmacogenetics, and experimental therapeutics; as well as clinicians interested in how the AI applications are integrated with applications with focus on digital pathology and personalized medicine.